What's New
-
2025-10-23
(23 October 2025, Hong Kong) HKSH Medical Group (HKSH) is proud to announce the world’s first clinical study on stereotactic total ablative radiotherapy (STAR) with an MR-guided linear accelerator (MR-LINAC) for oligometastatic prostate cancer (OMPC). This study involved patients with advanced metastatic prostate cancer, utilising real-time motion tracking and precise image-... -
2025-10-21
(21 October 2025, Hong Kong) HKSH Medical Group (HKSH) introduced Hong Kong’s only and the Greater Bay Area’s first proton therapy system in 2023, after two decades of planning and preparation. Now that the HKSH Proton Therapy Centre has been in operation for two years, following the “Proton Therapy Joint Training Course” coorganised with the National Cancer Center in Beijing... -
2025-09-26
(26 September 2025, Hong Kong) HKSH Medical Group (HKSH), in collaboration with the Hong Kong Eastern District Community Association, St. James’ Settlement, and the Hong Kong Island Federation Eastern District Committee, co-organised the “HKSH Eastern Health Festival”. The Festival featured a variety of health talks and free health check-up for children, adults, and elderly,...
